1426PLongitudinal plasma monitoring of subjects treated with EGFR-TKIs allows better understanding of evolution of acquired resistance and can inform optimal treatment strategies. (23rd October 2018) - Palma, J; Vitazka, P; Tikoo, N; Balasubramanyam, A; Xi, L; Yaung, S; Kwok, E; Lovejoy, A; Klass, D; Heibeck, M; Probst, K; Rehfeldt, A; et al.